Metabolic and functional effects of exercise training in diabetic kidney transplant recipients

Table 2 Lipid and glucose profile at the beginning and the end of the 6-mo clinical trial

	Exercise group			Control group			Exercise vs control group
	Baseline	After 6-mo	P value	Baseline	After 6-mo	P value	Pre	Post
FPG (mg/dL)	120.6 ± 28.9	104.8 ± 21.9	0.01	116.1 ± 33.2	115.4 ± 33.9	0.38	0.47	< 0.05
TC (mg/dL)	224.8 ± 30.4	224.0 ± 30.1	0.11	229.7 ± 28.8	230.8 ± 27.8	0.60	0.41	0.48
TG (mg/dL)	164.7 ± 14.8	150.8 ± 11.6	< 0.05	165.4 ± 19.0	165.2 ± 20.5	0.67	0.11	0.04
HDL (mg/dL)	51.4 ± 8.8	57.2 ± 8.7	< 0.05	51.1 ± 7.9	51.3 ± 12.6	0.43	0.56	0.06
LDL (mg/dL)	119.6 ± 11.4	119.4 ± 10.9	0.27	119.4 ± 17.0	119.5 ± 16.4	0.33	0.78	0.45
HbA1c (%)	6.7 ± 0.4	6.6 ± 0.4	0.01	6.5 ± 1.0	6.5 ± 1.1	0.25	0.20	0.36

Data are expressed as mean ± SD. P > 0.05: Baseline vs 6 mo follow-up; P > 0.05 and P < 0.05: Exercise vs control group. FPG: Fasting plasma glucose; TC: Total cholesterol; TG: Triglycerides; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; HbA1c: Hemoglobin A1c.